KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
KemPharm (KMPH) - Total assets
Total assets on the balance sheet as of December 2022 : $0.11 B
According to KemPharm's latest financial reports the company's total assets are $0.11 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
KemPharm - Total assets on balance sheet (from 2014 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.11 B | -13.1% |
| 2021-12-31 | $0.13 B | 1086.02% |
| 2020-12-31 | $11.2 M | 6.68% |
| 2019-12-31 | $10.5 M | -60.72% |
| 2018-12-31 | $26.74 M | -49.01% |
| 2017-12-31 | $52.45 M | -38.2% |
| 2016-12-31 | $84.88 M | 52.34% |
| 2015-12-31 | $55.72 M | 306.33% |
| 2014-12-31 | $13.71 M | 464.59% |
| 2013-12-31 | $2.42 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $0.38 B | 230.65% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $11.32 B | 9,704.55% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $0.90 B | 682.85% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $10.25 M | -91.12% | 🇺🇸 USA |